CA
NZ
UK
AU
IND
US
Robinhood Markets, Inc. filed a Form 4 on August 19, 2026, disclosing the sale of Common Shares of Beneficial Interest in Robinhood Ventures Fund I across two trading days, August 17 and August 18, 2026.
William John Miller, CEO and Director of Veeco Instruments Inc. (NASDAQ:VECO), filed a Form 4 on August 19, 2026, disclosing the sale of 200,000 shares of common stock across three transactions on August 17, 2026, executed under a Rule 10b5-1 plan.
Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc., filed a statement of changes in beneficial ownership with the SEC on August 19, 2026, reporting a disposition of common stock on August 15, 2026, in connection with restricted stock unit vesting.
A Form 4 filed on August 19, 2026 discloses that Nayda Rivera, Executive Vice President, Chief Compliance Officer, and Chief of Staff at First BanCorp /PR/ (NYSE:FBP), sold 10,000 shares of common stock on August 17, 2026.
Charles van Es, Chief Commercial Officer of Vita Coco Company, Inc. (NASDAQ:COCO), filed a Form 4 on August 19, 2026, disclosing a disposition of 10,801 shares of common stock on August 15, 2026, in connection with the vesting and settlement of Restricted Stock Units.
Louis Edward Tamayo, Chief Financial Officer of Lexeo Therapeutics, Inc. (NASDAQ:LXEO), filed a statement of changes in beneficial ownership on August 19, 2026, reporting a sale of common stock on August 18, 2026, executed to cover tax obligations arising from the release of restricted …
Brad Williams, President of Cadre Holdings, Inc. (NYSE:CDRE), filed a Form 4 on August 19, 2026, reporting stock option exercises and open-market sales of common stock that occurred on August 17, 2026.
Jose Manuel Otero, Chief Operating Officer of Lexeo Therapeutics, Inc. (NASDAQ:LXEO), filed a Form 4 on August 19, 2026, disclosing a sale of common stock on August 18, 2026, to cover tax obligations arising from the vesting of restricted stock units.
Richard Nolan Townsend, Chief Executive Officer and Director of Lexeo Therapeutics, Inc., filed a Form 4 on August 19, 2026, disclosing a sale of 3,345 shares of common stock on August 18, 2026, to cover tax obligations arising from the release of restricted stock …
A Form 4 filed with the SEC on August 18, 2026, discloses that Roger A. Baker, a director of HBT Financial, Inc. (NASDAQ:HBT), transferred 15,000 shares of common stock to a charitable organization at a price of $0 per share on August 18, 2026.
Please wait processing your request...